Tissue Glue and Bio-adhesive Sealants Market
Global Market Study on Tissue Glue and Bio-adhesive Sealants: ASCs End User Segment Expected to Register a Gradual Growth Rate over the Forecast Period
Tissue Glue and Bio Adhesive Sealants Market Segmented By Protein Based Sealants Collagen Based Sealants, Thrombin-based Sealants, Fibrin Sealant, Gelatin-based Sealants for Cardiovascular Surgery, Laparoscopic Surgeries, Burns and Skin Grafting, Digestive, Cosmetic, Reconstructive and Hand Surgery, General Surgeries
Increasing cutting-edge product innovation worldwide along with emergence of antimicrobial tissue glues is expected to boost overall development of the global tissue glue and bio-adhesive sealants market
The global tissue glue and bio-adhesive sealants market was valued at US$ 1,156.3 Mn in 2015. The market is anticipated to register a CAGR of 8.0% and is expected to reach US$ 2,281.2 Mn by 2024, creating incremental opportunity of US$ 1,124.9 Mn between 2015 and 2024. The global tissue glue and bio-adhesive sealants market is expected to represent absolute $ opportunity of US$ 83.0 Mn in 2017 over 2016.
Increasing cardiovascular and orthopedic procedures worldwide is expected to fuel the global tissue glue and bio-adhesive sealants market revenue growth over the forecast period. Increasing disposable income coupled with ease of access of new surgical adhesives and sealants amongst end users is a major factor for rise in such procedures globally. A portion of the essential components driving the development of this market are the expanding number of surgical procedures over the globe.
Rising maturing populace, rising number of chronic diseases, and growing concerns for blood loss during surgeries globally is further going to spur market revenue growth over the forecast period.
Find Out More about the Report Coverage
- Baxter International Inc.
- Luna Innovations Incorporated
- B. Braun Melsungen AG
- Johnson and Johnson
- DENTSPLY SIRONA Inc.
- Cohera Medical, Inc.
- Chemence Medical, Inc.
- Tissuemed Ltd.
- C.R. Bard Inc.
- Integra LifeSciences Corporation
Usage of tissue glue in major surgeries is expected to drive the revenue growth of tissue glues from hospitals
Hospitals segment is expected to account for nearly 70% revenue share of the global tissue glue and bio-adhesive sealants market by 2016 end, and is expected to gain 270 BPS by 2024 over 2016. Hospitals segment is expected to register higher Y-o-Y growth throughout the forecast period in comparison with other segments owing to increasing visits of outpatients to hospitals for various treatments.
Specialty clinics segment is expected to account for nearly 20% revenue share of the global tissue glue and bio-adhesive sealants market by 2016 end and is expected to lose 120 BPS by 2024 over 2016. The demand for new surgical adhesives is increasing among practitioners, which is expected to fuel revenue growth of clinics segment in the global tissue glue and bio-adhesive sealants market over the forecast period.
- Hospitals end user segment is expected to create absolute $ opportunity of nearly US$ 60 Mn in 2017 over 2016
- By the end of 2024, this segment is projected to reach more than US$ 1,500 Mn, witnessing a CAGR of 8.5% over the forecast period
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Increasing number of benefits such as faster wound healing and early discharge of patients is expected to attract more number of surgeons opting for tissue glue for major surgeries in hospitals and specialty clinics
- Specialty clinics end user segment is expected to create absolute $ opportunity of more than US$ 15 Mn in 2017 over 2016
- By the end of 2024, this segment is projected to reach more than US$ 400 Mn, registering a CAGR of 7.2% over the forecast period
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
ASCs end user segment is expected to register a gradual growth rate over the forecast period
- ASCs end user segment is expected to create absolute $ opportunity of nearly US$ 10 Mn in 2017 over 2016
- By the end of 2024, this segment is projected to reach nearly US$ 275 Mn, registering a CAGR of 6.4% over the forecast period
Explore Persistence Market Research’s expertise in promulgation of the business !
Companies are increasingly focusing on technological advancements to capture a larger share of the market in tissue glues
Over the last few years, companies have been focusing on development of newer tissue glue and bio-adhesive sealants to target a range of consumers including infants and young and elder patients. Currently these surgical sealants are known for protecting the fragile, sensitive skin from injuries and help in containing infection transmission and cross-contamination.
New launched products such as TissueGlue skin adhesive (Cryolife), CoSeal (Baxter), and DERMABOND ADVANCED® Topical Skin Adhesive (Ethicon Inc.) are considered to be technological breakthroughs in the global tissue glue and bio-adhesive sealants market owing to their functional distinction from other available products in the market.
The Tissue Glue and Bio-adhesive Sealants Market is segmented as follows:
By End User
By Product Type